NCT04949802

Glaucoma Surgery Using the ViaLase Laser System

A Prospective Single Center Clinical Study for Femtosecond Laser Glaucoma Surgery Using the ViaLase Laser

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 22 (actual)
• Sponsor: Vialase, Inc. · Industry
• Sex: All
• Age: 35 Years
• Healthy volunteers: Not accepted

Summary

Prospective, single-center, multi-cohort clinical trial of ViaLase Laser for the reduction of IOP in patients with open angle glaucoma.

Detailed description

The purpose of study is to obtain initial evidence of safety of femtosecond laser glaucoma surgery using the ViaLase Laser for the treatment of open angle glaucoma. The ViaLase Laser System is intended to create apertures through the trabecular meshwork to reduce intraocular pressure in patients with open angle glaucoma.

Conditions

• Glaucoma
• Glaucoma, Open-Angle

Interventions

Type	Name	Description
DEVICE	ViaLase Laser	ViaLase Laser System to create an aperture through the trabecular meshwork for the reduction of IOP in subjects with primary open-angle glaucoma

Timeline

• Start date: 2020-09-01
• Primary completion: 2021-12-16
• Completion: 2021-12-16
• First posted: 2021-07-02
• Last updated: 2023-10-17
• Results posted: 2023-09-21

Locations

1 site across 1 country: Hungary

Regulatory

• FDA-regulated device study